Moldova vs South Sudan: Tuberculosis treatment success rate (% of new cases)
Moldova
85.0%
in 2023
South Sudan
85.0%
in 2023
Moldova rank
87th
South Sudan rank
87th
Tuberculosis treatment success rate (% of new cases) over time
- Moldova
- South Sudan
How they compare
Moldova currently reports 85.0% against 85.0% in South Sudan, a difference of 0.0%.
The two have swapped places 5 times across 13 shared years of data; in 2011 it was Moldova ahead.
Moldova ranks 87th and South Sudan ranks 87th of 203 countries.
Across the 2 decades both report, Moldova averaged higher in 1 and South Sudan in 1.
Head to head by decade
| Decade | Moldova | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.1% | 74.7% | 5.4% | Moldova |
| 2020s | 82.2% | 83.2% | 1.0% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Moldova or South Sudan?
- Moldova, at 85.0% against 85.0% in South Sudan as of 2023.
- What is the difference in tuberculosis treatment success rate between Moldova and South Sudan?
- 0.0%, with Moldova ahead.
- How many years of comparable data are there for Moldova and South Sudan?
- 13 years are reported by both, from 2011 to 2023.
- How do Moldova and South Sudan rank globally for tuberculosis treatment success rate?
- Moldova ranks 87th and South Sudan ranks 87th of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).